Unidad de Gestión Clínica de Genética, Reproducción y Medicina Fetal, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
PLoS One. 2011;6(12):e27894. doi: 10.1371/journal.pone.0027894. Epub 2011 Dec 2.
Retinitis Pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies characterised ultimately by the loss of photoreceptor cells. RP is the leading cause of visual loss in individuals younger than 60 years, with a prevalence of about 1 in 4000. The molecular genetic diagnosis of autosomal recessive RP (arRP) is challenging due to the large genetic and clinical heterogeneity. Traditional methods for sequencing arRP genes are often laborious and not easily available and a screening technique that enables the rapid detection of the genetic cause would be very helpful in the clinical practice. The goal of this study was to develop and apply microarray-based resequencing technology capable of detecting both known and novel mutations on a single high-throughput platform. Hence, the coding regions and exon/intron boundaries of 16 arRP genes were resequenced using microarrays in 102 Spanish patients with clinical diagnosis of arRP. All the detected variations were confirmed by direct sequencing and potential pathogenicity was assessed by functional predictions and frequency in controls. For validation purposes 4 positive controls for variants consisting of previously identified changes were hybridized on the array. As a result of the screening, we detected 44 variants, of which 15 are very likely pathogenic detected in 14 arRP families (14%). Finally, the design of this array can easily be transformed in an equivalent diagnostic system based on targeted enrichment followed by next generation sequencing.
色素性视网膜炎(RP)是一组遗传性视网膜营养不良,最终特征是感光细胞的丧失。RP 是 60 岁以下人群视力丧失的主要原因,患病率约为每 4000 人中有 1 人。由于遗传和临床异质性很大,常染色体隐性 RP(arRP)的分子遗传诊断具有挑战性。传统的 arRP 基因测序方法通常很繁琐,不易获得,因此能够快速检测遗传原因的筛选技术将非常有助于临床实践。本研究的目的是开发和应用基于微阵列的重测序技术,能够在单个高通量平台上同时检测已知和新突变。因此,使用微阵列对 102 名西班牙临床诊断为 arRP 的患者的 16 个 arRP 基因的编码区和外显子/内含子边界进行了重测序。通过直接测序证实了所有检测到的变异,并通过功能预测和对照中的频率评估了潜在的致病性。为了验证目的,将由先前鉴定的变化组成的 4 个阳性对照变体杂交在阵列上。通过筛选,我们在 14 个 arRP 家族(14%)中检测到了 15 个非常可能致病的 44 个变体。最后,该阵列的设计可以很容易地转化为基于靶向富集和下一代测序的等效诊断系统。